Login / Signup

Phase III randomized trial comparing intravenous to oral iron in patients with cancer-related iron deficiency anemia not on erythropoiesis stimulating agents.

Vanita NoronhaAmit JoshiVijay Maruti PatilShripad D BanavaliSudeep GuptaPurvish M ParikhShalaka MarfatiaSachin PunatarSucheta MoreSupriya GoudDipti NaktiKumar Prabhash
Published in: Asia-Pacific journal of clinical oncology (2017)
IV iron was not superior to oral iron in patients with malignancy on chemotherapy and iron deficiency anemia.
Keyphrases
  • iron deficiency
  • phase iii
  • open label
  • clinical trial
  • high dose
  • phase ii
  • double blind
  • randomized controlled trial
  • squamous cell carcinoma
  • radiation therapy
  • study protocol
  • drug induced